IEQ Capital’s INmune Bio INMB Stock Holding History

IEQ Capital’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Buy	82,385 +57,822	+235%	+$80K	﹤0.01%	1897
2026 Q1	$27.8K	Buy	+24,563	New	+$35K	﹤0.01%	1863

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

IEQ Capital's INMB Position: Q2 2026 in Review

IEQ Capital increased its INmune Bio (INMB) stake by 235% in Q2 2026, buying an estimated $80K and bringing the position to 82,385 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

IEQ Capital first reported a position in INMB in Q1 2026 and has held it in 2 quarters since. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

IEQ Capital held 82,385 shares of INmune Bio worth $134K as of Q2 2026.
IEQ Capital bought 57,822 INmune Bio shares in Q2 2026, an estimated $80K.
INmune Bio made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1897 holding.
IEQ Capital first reported a position in INmune Bio in Q1 2026 and has held it in 2 quarters since.
83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.